Bone News and Research

RSS

Severe combined immunodeficiency treated successfully with gene therapy

Gene therapy can offer a cure for a rare condition that causes children’s immune systems to fail. In this rare condition, known as Severe Combined Immunodeficiency (SCID), inherited genetic mutations mean that babies are unable to fight off infection, severely limiting their chances of surviving more than a few years. Severe combined immunodeficiency (SCID) is a rare genetic disorder estimated to affect between 1 in 200,000 and 1 in 1,000,000 live births

26 Aug 2011

NeoStem featured on CBS's Eye on New York City

NeoStem, Inc., an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced that the Company was featured on CBS's Eye on New York City on Wednesday evening, August 24, 2011.

26 Aug 2011

Kettering University's biodegradable magnesium alloy can repair traumatic bone injury

Repairing traumatic injury to a bone is possible, but current procedures require multiple surgeries and long-term recovery. Kettering University's Dr. Montserrat Rabago-Smith and her team of co-researchers are exploring the use of a magnesium orthotic alloy in severe trauma injuries where the distance between two halves of a bone can't be overcome by the human body's ability to regenerate and heal.

26 Aug 2011

Study: Bone marrow transplantation may prolong period of cancer-free survival

Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a study led by Dr. Vivek Rangnekar, associate director of translational research for the Markey Cancer Center at the University of Kentucky.

25 Aug 2011

IGF1 plays key role in T-cell acute lymphoblastic leukemia

There are numerous specialized growth factors that are responsible for cells of different tissues of our body to divide and differentiate when needed. These hormone-like factors bind to matching receptors on the surface of their target cells and thus give order for the cell to divide. However, a single genetic alteration can be sufficient for the whole system to get out of control.

24 Aug 2011

Mouthguards can help reduce injuries in student athletes

As student athletes prepare to return to school, it's crucial they wear protective gear, like mouthguards, even when playing sports not usually associated with contact. A properly fitted mouthguard can help save your child's smile and keep them off the injured list.

24 Aug 2011

Craniofacial surgeons employ bipolar electrocautery to temporarily reshape the brain

Plastic surgeons say they have developed a new surgical technique for complex skull reconstruction that could improve functional and aesthetic outcomes in cases that have previously been deemed impossible or unsafe and left patients with unsightly skull deformities requiring them to wear a helmet.

24 Aug 2011

Cedars-Sinai named one of 'Hospitals with Great Orthopaedic Programs'

Cedars-Sinai's Orthopaedic Center is one of only 60 hospitals nationwide to be named as one of the "Hospitals with Great Orthopaedic Programs," a distinction awarded by Becker's Hospital Review, a national magazine focused on healthcare services and management.

24 Aug 2011

First North American clinical trial to test adult MSC transplantation as a new MS therapy

A team of researchers at three landmark Cleveland institutions have come together to launch a new clinical trial of an experimental treatment for multiple sclerosis.

24 Aug 2011

MDA announces $13.7M in grants to 40 new muscular dystrophy research initiatives

The Muscular Dystrophy Association today announced funding, totaling $13.7 million, for 40 new research initiatives targeting nearly two dozen progressive neuromuscular diseases.

24 Aug 2011

Study: More attention needs to be paid for cartilage during RA diagnosis

This could lead to a paradigm shift in the treatment of rheumatoid arthritis: rheumatologists at the Medical University of Vienna have discovered, through a secondary study involving 3,000 female patients, that the condition of the cartilage in inflammatory joint rheumatism needs to be paid more attention than has previously been the case. Until now, the focus lay mainly on investigating the damage to the bone.

23 Aug 2011

Radium-223 chloride granted FDA Fast Track designation for treatment of CRPC

Algeta ASA, a company focused on the development of novel targeted cancer therapeutics, today announced that radium-223 chloride has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of castration-resistant (hormone refractory) prostate cancer in patients with bone metastases.

23 Aug 2011

Stem cells of oral mucosa stay young, says Tel Aviv University researcher

While highly potent embryonic stem cells are often the subject of ethical and safety controversy, adult-derived stem cells have other problems. As we age, our stem cells are less pliant and less able to transform into the stem cells that science needs to find breakthrough treatments for disease.

23 Aug 2011

MME, WNDM sign major agreement to distribute CellerateRX

Wound Management Technologies, Inc., a leader in advanced wound care solutions, today announced a major distribution deal with Marketing Media Enterprises, LLC (MME), an Orlando Florida medical products distributor serving the direct-to-consumer and military market.

23 Aug 2011

Texas Gov. Rick Perry tries experimental stem cell therapy

Texas Gov. Rick Perry last month underwent a procedure where stem cells, made from fat taken from his body, were put into his bloodstream to see if they might find their way to help heal the bones in his back.

22 Aug 2011

Scientists report molecular structural basis for sex organ, head deformities

Scientists this month reported the molecular structural basis for severe head deformities and ambiguous sex organs in babies born with Antley-Bixler syndrome accompanied by an enzyme deficiency.

20 Aug 2011

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

The U.S. Food and Drug Administration today approved Adcetris to treat Hodgkin lymphoma and a rare lymphoma known as systemic anaplastic large cell lymphoma.

20 Aug 2011

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Amgen today announced that it will present data from several Prolia (denosumab) studies, including eight year efficacy and safety data from a Phase 2 extension study in women with postmenopausal osteoporosis with low bone mineral density (BMD), at the 2011 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in San Diego, Calif. from Sept. 16-20, 2011.

19 Aug 2011

IRSF announces new Rett syndrome translational research awards

The International Rett Syndrome Foundation (IRSF) announced today that it is awarding over $650,000 to support eight cutting-edge projects that aim to accelerate translational research to develop treatments for Rett syndrome.

19 Aug 2011

$Dried plums can protect postmenopausal women against fractures, osteoporosis$

Dried plums can protect postmenopausal women against fractures, osteoporosis

When it comes to improving bone health in postmenopausal women — and people of all ages, actually — a Florida State University researcher has found a simple, proactive solution to help prevent fractures and osteoporosis: eating dried plums.

19 Aug 2011